EUVIMED · CrossrefZeitschrift
Respiratory Investigation
ISSN 2212-5345 · Elsevier BV
Neueste Artikel
Outcomes of elderly hospitalized patients with influenza after the COVID-19 pandemic: decline of functional independence and frailty
Clinical significance of the COPD assessment test in evaluating treatment response in Mycobacterium avium complex pulmonary disease
Serum decoy receptor 3 is a possible prognostic biomarker in acute exacerbation of idiopathic interstitial pneumonia
Successful tarlatamab treatment with concomitant oral corticosteroids and anticonvulsants in small-cell lung cancer with unstable brain metastases: A case report
Clinical features, pathogenesis, and treatment of anti-MDA5 antibody-positive interstitial lung disease
Short- and long-term outcomes of anti-thymocyte globulin-based regimen for acute antibody-mediated rejection after lung transplantation
Nontuberculous mycobacterial pulmonary disease: Epidemiology, prognostic determinants, and implications for treatment decision
Impact of erythromycin discontinuation owing to supply disruption on exacerbations in non-cystic fibrosis bronchiectasis: A retrospective cohort study
Blood flow restriction training in COPD: A systematic review with exploratory meta-analysis of emerging evidence
Summary of the Japanese Respiratory Society guidelines for the diagnosis and treatment of asthma and chronic obstructive pulmonary disease overlap 2023 (2nd edition)
Identifying high-risk smokers without airflow limitation using new COPD criteria: pooled analysis of two Japanese cohorts
Impact of the COVID-19 pandemic on acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study in Japan
The role of ultrasound-guided cervical lymph node biopsy in lung cancer: A scoping review
Desaturation in the six-minute walk test predicts progressive pulmonary fibrosis in fibrotic interstitial lung disease
Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors – Summary of recommendations
Differential associations between type 2 inflammation and airway mucus plugs in asthma, asthma-COPD overlap, and COPD
Immune checkpoint inhibitor-related pneumonitis: From guidelines to the front lines
Macrolide-resistant Mycoplasma pneumoniae infection prevalence increases again in Osaka
The hygiene environment during childhood may affect susceptibility to sarcoidosis: A case-control study of environmental risk factors
Mechanisms of resistance to antibody–drug conjugates in cancers
Guidance for type 2 inflammatory biomarkers
Clinical interpretation of DLCO and KCO: From rationale to clinical and research applications
Prognostic prediction for newly diagnosed patients with idiopathic interstitial pneumonia: JIPS Registry (NEJ030)
Sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors on in-hospital mortality following pneumonia without heart failure: A retrospective cohort study of older adults with diabetes
Safe surgical lung biopsy in the diagnosis of interstitial lung disease under strict patient selection
Clinical research using real-world data: A narrative review
Responsiveness and minimal clinically important difference of the COPD Assessment Test in fibrotic interstitial lung disease
Multidisciplinary team discussion based on etiological treatment improves refractory chronic cough outcomes
Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017–2021
Burden of respiratory syncytial virus infections in older adults with acute respiratory infection in Japan: An epidemiological study among outpatients
EUVIMED